CellaVision AB (publ) (STO:CEVI)
181.60
+1.80 (1.00%)
Sep 10, 2025, 11:48 AM CET
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 4.29 billion as of September 10, 2025. Its market cap has decreased by -29.21% in one year.
Market Cap
4.29B
Enterprise Value
4.16B
Revenue
751.47M
Ranking
n/a
PE Ratio
28.37
Stock Price
181.60
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 4.29B, an increase of 1,052.54%. That is a compound annual growth rate of 14.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 4.29B | -17.33% |
Dec 30, 2024 | 5.19B | 2.59% |
Dec 29, 2023 | 5.06B | -7.42% |
Dec 30, 2022 | 5.46B | -29.58% |
Dec 30, 2021 | 7.76B | 5.93% |
Dec 30, 2020 | 7.32B | -3.91% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 95.97B |
Sectra AB | 63.73B |
Getinge AB | 57.14B |
Camurus AB | 43.05B |
Medicover AB | 40.46B |
Asker Healthcare Group AB | 36.45B |
BioArctic AB | 25.72B |
AddLife AB | 21.67B |